Table 1.
Details of cases used in this study
| Case no. | Pathological diagnosis | Gender | Age at onset | Age at death | Duration |
|---|---|---|---|---|---|
| 1 | Normal control | M | NA | 85 | NA |
| 2 | Normal control | F | NA | 82 | NA |
| 3 | Normal control | M | NA | 57 | NA |
| 4 | Normal control | F | NA | 79 | NA |
| 5 | Normal control | F | NA | 94 | NA |
| 6 | Normal control | M | NA | 71 | NA |
| 7 | Normal control | F | NA | 68 | NA |
| 8 | Normal control | F | NA | 80 | NA |
| 9 | Normal control | M | NA | 69 | NA |
| 10 | Normal control | F | NA | 93 | NA |
| 11 | C9FTLD-TDP type A | M | 62 | 72 | 10 |
| 12 | C9FTLD-TDP type A | F | 66 | 74 | 8 |
| 13 | C9FTLD-TDP type A | M | 43 | 45 | 2 |
| 14 | C9FTLD-TDP type B | F | 64 | 66 | 2 |
| 15 | C9FTLD-TDP type A | M | 53 | 63 | 10 |
| 16 | C9FTLD-TDP type A | M | 62 | 68 | 6 |
| 17 | C9FTLD-TDP type A | F | 56 | 67 | 11 |
| 18 | C9FTLD-TDP type A | M | 54 | 60 | 6 |
| 19 | FTLD-TDP type A | M | 57 | 62 | 5 |
| 20 | FTLD-TDP type A | M | 75 | 79 | 4 |
| 21 | FTLD-TDP type A | F | 75 | 78 | 3 |
| 22 | FTLD-TDP type A | F | 83 | 87 | 4 |
| 23 | FTLD-TDP type B | F | 75 | 77 | 2 |
| 24 | FTLD-TDP type B | F | 63 | 67 | 4 |
| 25 | FTLD-TDP type B | M | 67 | 69 | 2 |
| 26 | AD | F | 67 | 76 | 9 |
| 27 | AD | M | 60 | 66 | 6 |
| 28 | AD | F | 51 | 62 | 11 |